CLINICAL_TRIALS
trial_result
· 2021-10-20
Clinical Trial Update: Clinical Trial of Glatiramer Acetate in Amyotrophic Lateral Sclerosis (ALS) [Phase 2]
Summary
Phase 2 trial of glatiramer acetate in amyotrophic lateral sclerosis has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Teva Pharmaceutical Industries, Ltd. | Conditions: Amyotrophic Lateral Sclerosis | Phase 2 | Status: COMPLETED | Results posted: 2021-10-20